Jean I Liu Seagen Inc. (SGEN) insider trading activity

SGEN Quotes by TradingView

Jean I Liu is Chief Legal Officer of Seagen Inc.. Currently has a direct ownership of 0 shares of SGEN, which is worth approximately $0. The most recent transaction as insider was on Nov 17, 2022, when has been sold 8,333 shares (Common Stock) at a price of $34.2 per share, resulting in proceeds of $284,988. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

JEAN I LIU Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2022
BUY
Exercise of conversion of derivative security
$284,988 $34.2 p/Share
8,333 Added 8.14%
94,024 Common Stock
Nov 14 2022
BUY
Exercise of conversion of derivative security
$99,994 $76.86 p/Share
1,301 Added 1.5%
85,691 Common Stock
Aug 31 2022
SELL
Open market or private sale
$563,288 $154.41 p/Share
3,648 Reduced 4.14%
84,390 Common Stock
Aug 16 2022
SELL
Open market or private sale
$278,991 $170.22 p/Share
1,639 Reduced 1.83%
88,038 Common Stock
Aug 15 2022
BUY
Grant, award, or other acquisition
-
13,731 Added 13.28%
89,677 Common Stock
Apr 20 2022
SELL
Open market or private sale
$57,872 $144.32 p/Share
401 Reduced 0.53%
75,946 Common Stock
Jan 18 2022
BUY
Grant, award, or other acquisition
-
5,915 Added 7.19%
76,347 Common Stock
Dec 20 2021
SELL
Open market or private sale
$41,359 $149.85 p/Share
276 Reduced 0.39%
70,432 Common Stock
Nov 04 2021
BUY
Exercise of conversion of derivative security
$74,980 $46.37 p/Share
1,617 Added 2.24%
70,708 Common Stock
Nov 01 2021
SELL
Open market or private sale
$6,142,710 $176.13 p/Share
34,876 Reduced 33.55%
69,091 Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
$1,253,792 $35.95 p/Share
34,876 Added 25.12%
103,967 Common Stock
Sep 23 2021
BUY
Grant, award, or other acquisition
$26,595 $166.22 p/Share
160 Added 0.23%
69,091 Common Stock
Aug 31 2021
SELL
Open market or private sale
$611,113 $167.52 p/Share
3,648 Reduced 5.03%
68,931 Common Stock
Aug 16 2021
SELL
Open market or private sale
$110,967 $154.55 p/Share
718 Reduced 1.12%
63,333 Common Stock
Aug 16 2021
BUY
Grant, award, or other acquisition
-
9,246 Added 11.3%
72,579 Common Stock
May 11 2021
SELL
Open market or private sale
$148,540 $140.0 p/Share
1,061 Reduced 1.63%
64,051 Common Stock
Feb 17 2021
BUY
Exercise of conversion of derivative security
$206,149 $42.54 p/Share
4,846 Added 6.93%
65,112 Common Stock
Jan 15 2021
SELL
Open market or private sale
$900,000 $180.0 p/Share
5,000 Reduced 7.66%
60,266 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
$179,750 $35.95 p/Share
5,000 Added 7.12%
65,266 Common Stock
Dec 16 2020
BUY
Exercise of conversion of derivative security
$58,383 $35.95 p/Share
1,624 Added 2.62%
60,266 Common Stock
Dec 14 2020
SELL
Open market or private sale
$979,850 $195.97 p/Share
5,000 Reduced 7.86%
58,642 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$179,750 $35.95 p/Share
5,000 Added 7.28%
63,642 Common Stock

Also insider at

ERAS
Erasca, Inc. Healthcare
Director
JIL

Jean I Liu

Chief Legal Officer
Bothell, WA

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGEN